| Institution: | 1. Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangzhou 510006, China; Institute of Chinese Medicine, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, China;2. The Department of Endocrinology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China;3. Department of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China;1. Department of Nephrology, Institute of Nephrology of Chongqing and Kidney Center of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China;2. State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury of PLA, Third Military Medical University, Chongqing 400038, China;1. Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt;2. Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt;3. Department of Ophthalmology, Augusta University, Augusta, GA 30912, USA |
